Stayble Therapeutics AB (publ) (FRA:4K4)

Germany flag Germany · Delayed Price · Currency is EUR
0.0028
0.00 (0.00%)
Last updated: Apr 24, 2026, 3:25 PM CET
Market Cap199.35K -91.7%
Revenue (ttm)n/a
Net Income-640.17K
EPS-0.01
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume188
Open0.0028
Previous Close0.0028
Day's Range0.0028 - 0.0038
52-Week Range0.0024 - 0.0489
Betan/a
RSI16.94
Earnings DateMay 21, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4K4

Financial Performance

Financial numbers in SEK Financial Statements